Search clinical trials for: Selinexor
Total 177 results
-
National University Hospital, SingaporeRecruitingAdvanced Refractory Solid Tumors | Advanced Triple Negative Breast Cancers | Metastatic Triple Negative Breast CancersSingapore
-
European Myeloma NetworkKaryopharm Therapeutics IncRecruitingMultiple MyelomaSpain, United States, Germany, Netherlands, Greece, France, Italy
-
Juan DuRecruitingMultiple MyelomaChina
-
University of Colorado, DenverNational Cancer Institute (NCI); Karyopharm Therapeutics IncRecruitingMultiple Myeloma in RelapseUnited States
-
St. Jude Children's Research HospitalAbbVie; Gateway for Cancer Research; Karyopharm Therapeutics IncRecruitingRefractory Acute Myeloid Leukemia | Acute Myeloid Leukemia, in Relapse | Acute Leukemia of Ambiguous Lineage in Relapse | Refractory Acute Leukemia of Ambiguous LineageUnited States
-
Li ZhengNot yet recruiting
-
Chunyan Sun, MDRecruiting
-
Mamta ParikhNational Cancer Institute (NCI); Karyopharm Therapeutics IncRecruitingMetastatic Urothelial Carcinoma | Locally Advanced Urothelial Carcinoma | Advanced Urothelial Carcinoma | Refractory Urothelial CarcinomaUnited States
-
National University Hospital, SingaporeRecruitingMetastatic Solid Malignancies | Advance Solid MalignanciesSingapore
-
US Oncology ResearchKaryopharm Therapeutics IncRecruitingMultiple Myeloma | Plasma Cell Myeloma | Myeloma-Multiple | Myeloma Multiple | Kahler Disease | Myeloma, Plasma Cell | MyelomatosisUnited States
-
Mayo ClinicNational Cancer Institute (NCI)RecruitingRefractory Multiple Myeloma | Recurrent Multiple MyelomaUnited States
-
Academic and Community Cancer Research UnitedNational Cancer Institute (NCI)RecruitingRefractory Plasma Cell Myeloma | Recurrent Plasma Cell MyelomaUnited States
-
Hackensack Meridian HealthKaryopharm Therapeutics IncRecruitingMultiple MyelomaUnited States
-
Mayo ClinicNational Cancer Institute (NCI)RecruitingRecurrent Hodgkin Lymphoma | Refractory Hodgkin Lymphoma | Refractory Plasma Cell Myeloma | Recurrent Histiocytic and Dendritic Cell Neoplasm | Recurrent Non-Hodgkin Lymphoma | Refractory Histiocytic and Dendritic Cell Neoplasm | Refractory Non-Hodgkin Lymphoma | Recurrent Plasma Cell MyelomaUnited States
-
Grupo Espanol de Investigacion en SarcomasRecruitingSarcoma,Soft TissueSpain
-
Karyopharm Therapeutics IncRecruitingMyelofibrosisUnited States, Korea, Republic of, Belgium, Italy, Spain, France, United Kingdom, Israel, Czechia, Taiwan, Canada, Germany, Romania, Bulgaria, Poland, Denmark
-
OncotherapeuticsKaryopharm Therapeutics IncRecruitingRefractory Multiple MyelomaUnited States
-
Karyopharm Therapeutics IncRecruitingRelapsed/Refractory Diffuse Large B-cell LymphomaUnited States, Spain, Israel, Italy, Poland, China, Austria
-
Karyopharm Therapeutics IncRecruiting
-
Karyopharm Therapeutics IncRecruitingOther Solid Tumors | Colorectal Cancer (CRC) | Non-Small Cell Lung Carcinoma (NSCLC)Israel
-
Multiple Myeloma Research ConsortiumEli Lilly and Company; GlaxoSmithKline; AbbVie; Takeda; Genentech, Inc.; Celgene Corporation and other collaboratorsRecruitingRelapsed Refractory Multiple MyelomaUnited States
-
PETHEMA FoundationRecruitingRefractory Multiple MyelomaSpain
-
Barbara Ann Karmanos Cancer InstituteNational Cancer Institute (NCI)RecruitingDiffuse Large B-Cell Lymphoma | Recurrent Mantle Cell Lymphoma | Recurrent Marginal Zone Lymphoma | Refractory B-Cell Non-Hodgkin Lymphoma | Recurrent B-Cell Non-Hodgkin Lymphoma | Refractory Mantle Cell Lymphoma | Recurrent Follicular Lymphoma | Refractory Follicular Lymphoma | Recurrent Waldenstrom... and other conditionsUnited States
-
Wake Forest University Health SciencesNational Cancer Institute (NCI)RecruitingUntreated Adult Acute Myeloid LeukemiaUnited States
-
Canadian Cancer Trials GroupRoche Pharma AG; Janssen, LP; Karyopharm Therapeutics IncRecruiting
-
Karyopharm Therapeutics IncRecruitingDiffuse Large B-cell LymphomaUnited Kingdom, United States, Australia, Austria, Belgium, Bulgaria, Canada, France, Germany, Greece, Hungary, India, Israel, Italy, Netherlands, New Zealand, Poland, Serbia, Spain
-
University of ChicagoNational Cancer Institute (NCI)RecruitingRefractory Multiple MyelomaUnited States
-
University of Texas Southwestern Medical CenterKaryopharm Therapeutics IncTerminatedNon-small Cell Lung CancerUnited States
-
Dana-Farber Cancer InstituteKaryopharm Therapeutics Inc; William Lawrence and Blanche Hughes FoundationActive, not recruitingRelapsed Acute Lymphoblastic Leukemia (ALL) | Refractory Acute Lymphoblastic Leukemia (ALL) | Relapsed Acute Myelogenous Leukemia (AML) | Refractory Acute Myelogenous Leukemia (AML) | Relapsed Mixed Lineage Leukemia | Refractory Mixed Lineage Leukemia | Relapsed Biphenotypic Leukemia | Refractory... and other conditionsUnited States
-
Karyopharm Therapeutics IncGOG Foundation; Israeli Society of Gynecologic Oncology; Belgium and Luxembourg... and other collaboratorsActive, not recruitingEndometrial CancerUnited States, China, Israel, Spain, Belgium, Germany, Greece, Czechia, Italy, Canada
-
National Cancer Institute (NCI)SuspendedRecurrent Glioblastoma, IDH-Wildtype | MGMT-Methylated Glioblastoma | Recurrent MGMT-Methylated GlioblastomaUnited States
-
Karyopharm Therapeutics IncActive, not recruitingMyelofibrosisSpain, China, Poland, United States, France, Greece, Italy
-
M.D. Anderson Cancer CenterNational Cancer Institute (NCI)Active, not recruitingMetastatic Renal Cell Carcinoma | Metastatic Lung Non-Small Cell Carcinoma | Stage IVA Lung Cancer AJCC v8 | Stage IVB Lung Cancer AJCC v8 | Metastatic Melanoma | Fallopian Tube Carcinoma | Advanced Malignant Solid Neoplasm | Stage III Lung Cancer AJCC v8 | Stage IV Lung Cancer AJCC v8 | Stage III Renal... and other conditionsUnited States
-
National Cancer Institute (NCI)Active, not recruitingGlioblastoma | Gliosarcoma | Newly DiagnosedUnited States
-
Karyopharm Therapeutics IncBristol-Myers SquibbActive, not recruitingMultiple MyelomaUnited States, Canada
-
Sanjay MohanAbbVie; Karyopharm Therapeutics IncActive, not recruitingAcute Myeloid Leukemia | Non-Hodgkin's Lymphoma | Diffuse Large B-cell LymphomaUnited States
-
Ida Bruun KristensenOdense Patient Data Explorative Network; Karyopharm Therapeutics IncActive, not recruitingMultiple MyelomaDenmark, Norway, Estonia
-
Antengene CorporationActive, not recruiting
-
St. Jude Children's Research HospitalWithdrawnRhabdoid Tumor | CNS Tumor | Atypical Teratoid/Rhabdoid Tumor | Atypical Teratoid/Rhabdoid Tumor of CNSUnited States
-
University of UtahKaryopharm Therapeutics IncActive, not recruitingPrimary Myelofibrosis | Post-polycythemia Vera Myelofibrosis | Post-essential Thrombocythemia MyelofibrosisUnited States
-
University Health Network, TorontoActive, not recruitingSoft Tissue Sarcoma | Leiomyosarcoma | Endometrial Stromal Sarcoma | Malignant Peripheral Nerve Sheath Tumor (MPNST)Canada
-
University of LeedsCompletedRelapsed or Refractory Multiple MyelomaUnited Kingdom
-
University Health Network, TorontoActive, not recruitingSalivary Gland Cancer | Metastatic | Recurrent | AdvancedCanada
-
Karyopharm Therapeutics IncCompletedSarcomaUnited States, Canada
-
Children's Oncology GroupNational Cancer Institute (NCI)Active, not recruitingMalignant Glioma | WHO Grade 3 Glioma | Refractory Lymphoma | Refractory Malignant Solid Neoplasm | Recurrent Lymphoma | Recurrent Malignant Solid Neoplasm | Refractory Primary Central Nervous System Neoplasm | Recurrent Childhood Central Nervous System Neoplasm | Recurrent Brain Neoplasm | Recurrent Childhood...United States
-
Stanford UniversityCompleted
-
Karyopharm Therapeutics IncActive, not recruitingLocally Advanced Unresectable or Metastatic MelanomaUnited States
-
Mohammed Najeeb Al HallakNational Cancer Institute (NCI)CompletedAcinar Cell Adenocarcinoma of the Pancreas | Duct Cell Adenocarcinoma of the Pancreas | Stage IV Pancreatic CancerUnited States
-
Karyopharm Therapeutics IncTerminated
-
Weill Medical College of Cornell UniversityKaryopharm Therapeutics IncTerminatedRefractory Multiple Myeloma | Myeloma | Myeloma MultipleUnited States